Global Tuberculosis Vaccines Market Growth 2025-2031

October 2025 | 95 pages | ID: G45FF90A21C6EN
LP Information

Abstracts

The global Tuberculosis Vaccines market size is predicted to grow from US$ 78.5 million in 2025 to US$ 93.5 million in 2031; it is expected to grow at a CAGR of 2.9% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.

United States market for Tuberculosis Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Tuberculosis Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Tuberculosis Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Tuberculosis Vaccines players cover Sanofi, Merck, Serum Institute of India, GlaxoSmithKline, Japan BCG Lab, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Tuberculosis Vaccines Industry Forecast? looks at past sales and reviews total world Tuberculosis Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Tuberculosis Vaccines sales for 2025 through 2031. With Tuberculosis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Tuberculosis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Tuberculosis Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Immunotherapeutic Vaccines
• Booster Vaccines
• Others

Segmentation by Application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Sanofi
• Merck
• Serum Institute of India
• GlaxoSmithKline
• Japan BCG Lab
• IDT Biologics
• GreenSignal Bio Pharma
• Taj Pharmaceuticals
• Bavarian Nordic
• China National Biotec Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Tuberculosis Vaccines market?
What factors are driving Tuberculosis Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tuberculosis Vaccines market opportunities vary by end market size?
How does Tuberculosis Vaccines break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tuberculosis Vaccines Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Tuberculosis Vaccines by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Tuberculosis Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Tuberculosis Vaccines Segment by Type
  2.2.1 Immunotherapeutic Vaccines
  2.2.2 Booster Vaccines
  2.2.3 Others
2.3 Tuberculosis Vaccines Sales by Type
  2.3.1 Global Tuberculosis Vaccines Sales Market Share by Type (2020-2025)
  2.3.2 Global Tuberculosis Vaccines Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Tuberculosis Vaccines Sale Price by Type (2020-2025)
2.4 Tuberculosis Vaccines Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Tuberculosis Vaccines Sales by Application
  2.5.1 Global Tuberculosis Vaccines Sale Market Share by Application (2020-2025)
  2.5.2 Global Tuberculosis Vaccines Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Tuberculosis Vaccines Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Tuberculosis Vaccines Breakdown Data by Company
  3.1.1 Global Tuberculosis Vaccines Annual Sales by Company (2020-2025)
  3.1.2 Global Tuberculosis Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Tuberculosis Vaccines Annual Revenue by Company (2020-2025)
  3.2.1 Global Tuberculosis Vaccines Revenue by Company (2020-2025)
  3.2.2 Global Tuberculosis Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Tuberculosis Vaccines Sale Price by Company
3.4 Key Manufacturers Tuberculosis Vaccines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Tuberculosis Vaccines Product Location Distribution
  3.4.2 Players Tuberculosis Vaccines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TUBERCULOSIS VACCINES BY GEOGRAPHIC REGION

4.1 World Historic Tuberculosis Vaccines Market Size by Geographic Region (2020-2025)
  4.1.1 Global Tuberculosis Vaccines Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Tuberculosis Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Tuberculosis Vaccines Market Size by Country/Region (2020-2025)
  4.2.1 Global Tuberculosis Vaccines Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Tuberculosis Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tuberculosis Vaccines Sales Growth
4.4 APAC Tuberculosis Vaccines Sales Growth
4.5 Europe Tuberculosis Vaccines Sales Growth
4.6 Middle East & Africa Tuberculosis Vaccines Sales Growth

5 AMERICAS

5.1 Americas Tuberculosis Vaccines Sales by Country
  5.1.1 Americas Tuberculosis Vaccines Sales by Country (2020-2025)
  5.1.2 Americas Tuberculosis Vaccines Revenue by Country (2020-2025)
5.2 Americas Tuberculosis Vaccines Sales by Type (2020-2025)
5.3 Americas Tuberculosis Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Tuberculosis Vaccines Sales by Region
  6.1.1 APAC Tuberculosis Vaccines Sales by Region (2020-2025)
  6.1.2 APAC Tuberculosis Vaccines Revenue by Region (2020-2025)
6.2 APAC Tuberculosis Vaccines Sales by Type (2020-2025)
6.3 APAC Tuberculosis Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Tuberculosis Vaccines by Country
  7.1.1 Europe Tuberculosis Vaccines Sales by Country (2020-2025)
  7.1.2 Europe Tuberculosis Vaccines Revenue by Country (2020-2025)
7.2 Europe Tuberculosis Vaccines Sales by Type (2020-2025)
7.3 Europe Tuberculosis Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tuberculosis Vaccines by Country
  8.1.1 Middle East & Africa Tuberculosis Vaccines Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Tuberculosis Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Tuberculosis Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Tuberculosis Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccines
10.3 Manufacturing Process Analysis of Tuberculosis Vaccines
10.4 Industry Chain Structure of Tuberculosis Vaccines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Tuberculosis Vaccines Distributors
11.3 Tuberculosis Vaccines Customer

12 WORLD FORECAST REVIEW FOR TUBERCULOSIS VACCINES BY GEOGRAPHIC REGION

12.1 Global Tuberculosis Vaccines Market Size Forecast by Region
  12.1.1 Global Tuberculosis Vaccines Forecast by Region (2026-2031)
  12.1.2 Global Tuberculosis Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Tuberculosis Vaccines Forecast by Type (2026-2031)
12.7 Global Tuberculosis Vaccines Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Sanofi
  13.1.1 Sanofi Company Information
  13.1.2 Sanofi Tuberculosis Vaccines Product Portfolios and Specifications
  13.1.3 Sanofi Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Sanofi Main Business Overview
  13.1.5 Sanofi Latest Developments
13.2 Merck
  13.2.1 Merck Company Information
  13.2.2 Merck Tuberculosis Vaccines Product Portfolios and Specifications
  13.2.3 Merck Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Merck Main Business Overview
  13.2.5 Merck Latest Developments
13.3 Serum Institute of India
  13.3.1 Serum Institute of India Company Information
  13.3.2 Serum Institute of India Tuberculosis Vaccines Product Portfolios and Specifications
  13.3.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Serum Institute of India Main Business Overview
  13.3.5 Serum Institute of India Latest Developments
13.4 GlaxoSmithKline
  13.4.1 GlaxoSmithKline Company Information
  13.4.2 GlaxoSmithKline Tuberculosis Vaccines Product Portfolios and Specifications
  13.4.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 GlaxoSmithKline Main Business Overview
  13.4.5 GlaxoSmithKline Latest Developments
13.5 Japan BCG Lab
  13.5.1 Japan BCG Lab Company Information
  13.5.2 Japan BCG Lab Tuberculosis Vaccines Product Portfolios and Specifications
  13.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Japan BCG Lab Main Business Overview
  13.5.5 Japan BCG Lab Latest Developments
13.6 IDT Biologics
  13.6.1 IDT Biologics Company Information
  13.6.2 IDT Biologics Tuberculosis Vaccines Product Portfolios and Specifications
  13.6.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 IDT Biologics Main Business Overview
  13.6.5 IDT Biologics Latest Developments
13.7 GreenSignal Bio Pharma
  13.7.1 GreenSignal Bio Pharma Company Information
  13.7.2 GreenSignal Bio Pharma Tuberculosis Vaccines Product Portfolios and Specifications
  13.7.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 GreenSignal Bio Pharma Main Business Overview
  13.7.5 GreenSignal Bio Pharma Latest Developments
13.8 Taj Pharmaceuticals
  13.8.1 Taj Pharmaceuticals Company Information
  13.8.2 Taj Pharmaceuticals Tuberculosis Vaccines Product Portfolios and Specifications
  13.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Taj Pharmaceuticals Main Business Overview
  13.8.5 Taj Pharmaceuticals Latest Developments
13.9 Bavarian Nordic
  13.9.1 Bavarian Nordic Company Information
  13.9.2 Bavarian Nordic Tuberculosis Vaccines Product Portfolios and Specifications
  13.9.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Bavarian Nordic Main Business Overview
  13.9.5 Bavarian Nordic Latest Developments
13.10 China National Biotec Group
  13.10.1 China National Biotec Group Company Information
  13.10.2 China National Biotec Group Tuberculosis Vaccines Product Portfolios and Specifications
  13.10.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 China National Biotec Group Main Business Overview
  13.10.5 China National Biotec Group Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Tuberculosis Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Tuberculosis Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immunotherapeutic Vaccines
Table 4. Major Players of Booster Vaccines
Table 5. Major Players of Others
Table 6. Global Tuberculosis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 7. Global Tuberculosis Vaccines Sales Market Share by Type (2020-2025)
Table 8. Global Tuberculosis Vaccines Revenue by Type (2020-2025) & ($ million)
Table 9. Global Tuberculosis Vaccines Revenue Market Share by Type (2020-2025)
Table 10. Global Tuberculosis Vaccines Sale Price by Type (2020-2025) & (USD/Dose)
Table 11. Global Tuberculosis Vaccines Sale by Application (2020-2025) & (K Doses)
Table 12. Global Tuberculosis Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global Tuberculosis Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global Tuberculosis Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global Tuberculosis Vaccines Sale Price by Application (2020-2025) & (USD/Dose)
Table 16. Global Tuberculosis Vaccines Sales by Company (2020-2025) & (K Doses)
Table 17. Global Tuberculosis Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global Tuberculosis Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Tuberculosis Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global Tuberculosis Vaccines Sale Price by Company (2020-2025) & (USD/Dose)
Table 21. Key Manufacturers Tuberculosis Vaccines Producing Area Distribution and Sales Area
Table 22. Players Tuberculosis Vaccines Products Offered
Table 23. Tuberculosis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Tuberculosis Vaccines Sales by Geographic Region (2020-2025) & (K Doses)
Table 27. Global Tuberculosis Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global Tuberculosis Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Tuberculosis Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Tuberculosis Vaccines Sales by Country/Region (2020-2025) & (K Doses)
Table 31. Global Tuberculosis Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global Tuberculosis Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Tuberculosis Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Tuberculosis Vaccines Sales by Country (2020-2025) & (K Doses)
Table 35. Americas Tuberculosis Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas Tuberculosis Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Tuberculosis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 38. Americas Tuberculosis Vaccines Sales by Application (2020-2025) & (K Doses)
Table 39. APAC Tuberculosis Vaccines Sales by Region (2020-2025) & (K Doses)
Table 40. APAC Tuberculosis Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC Tuberculosis Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Tuberculosis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 43. APAC Tuberculosis Vaccines Sales by Application (2020-2025) & (K Doses)
Table 44. Europe Tuberculosis Vaccines Sales by Country (2020-2025) & (K Doses)
Table 45. Europe Tuberculosis Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Tuberculosis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 47. Europe Tuberculosis Vaccines Sales by Application (2020-2025) & (K Doses)
Table 48. Middle East & Africa Tuberculosis Vaccines Sales by Country (2020-2025) & (K Doses)
Table 49. Middle East & Africa Tuberculosis Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Tuberculosis Vaccines Sales by Type (2020-2025) & (K Doses)
Table 51. Middle East & Africa Tuberculosis Vaccines Sales by Application (2020-2025) & (K Doses)
Table 52. Key Market Drivers & Growth Opportunities of Tuberculosis Vaccines
Table 53. Key Market Challenges & Risks of Tuberculosis Vaccines
Table 54. Key Industry Trends of Tuberculosis Vaccines
Table 55. Tuberculosis Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Tuberculosis Vaccines Distributors List
Table 58. Tuberculosis Vaccines Customer List
Table 59. Global Tuberculosis Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 60. Global Tuberculosis Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Tuberculosis Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 62. Americas Tuberculosis Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Tuberculosis Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 64. APAC Tuberculosis Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Tuberculosis Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 66. Europe Tuberculosis Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Tuberculosis Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 68. Middle East & Africa Tuberculosis Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Tuberculosis Vaccines Sales Forecast by Type (2026-2031) & (K Doses)
Table 70. Global Tuberculosis Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Tuberculosis Vaccines Sales Forecast by Application (2026-2031) & (K Doses)
Table 72. Global Tuberculosis Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Sanofi Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Sanofi Tuberculosis Vaccines Product Portfolios and Specifications
Table 75. Sanofi Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 76. Sanofi Main Business
Table 77. Sanofi Latest Developments
Table 78. Merck Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Tuberculosis Vaccines Product Portfolios and Specifications
Table 80. Merck Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Serum Institute of India Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Serum Institute of India Tuberculosis Vaccines Product Portfolios and Specifications
Table 85. Serum Institute of India Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 86. Serum Institute of India Main Business
Table 87. Serum Institute of India Latest Developments
Table 88. GlaxoSmithKline Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. GlaxoSmithKline Tuberculosis Vaccines Product Portfolios and Specifications
Table 90. GlaxoSmithKline Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 91. GlaxoSmithKline Main Business
Table 92. GlaxoSmithKline Latest Developments
Table 93. Japan BCG Lab Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Japan BCG Lab Tuberculosis Vaccines Product Portfolios and Specifications
Table 95. Japan BCG Lab Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. Japan BCG Lab Main Business
Table 97. Japan BCG Lab Latest Developments
Table 98. IDT Biologics Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. IDT Biologics Tuberculosis Vaccines Product Portfolios and Specifications
Table 100. IDT Biologics Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 101. IDT Biologics Main Business
Table 102. IDT Biologics Latest Developments
Table 103. GreenSignal Bio Pharma Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. GreenSignal Bio Pharma Tuberculosis Vaccines Product Portfolios and Specifications
Table 105. GreenSignal Bio Pharma Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 106. GreenSignal Bio Pharma Main Business
Table 107. GreenSignal Bio Pharma Latest Developments
Table 108. Taj Pharmaceuticals Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Taj Pharmaceuticals Tuberculosis Vaccines Product Portfolios and Specifications
Table 110. Taj Pharmaceuticals Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 111. Taj Pharmaceuticals Main Business
Table 112. Taj Pharmaceuticals Latest Developments
Table 113. Bavarian Nordic Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Bavarian Nordic Tuberculosis Vaccines Product Portfolios and Specifications
Table 115. Bavarian Nordic Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 116. Bavarian Nordic Main Business
Table 117. Bavarian Nordic Latest Developments
Table 118. China National Biotec Group Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. China National Biotec Group Tuberculosis Vaccines Product Portfolios and Specifications
Table 120. China National Biotec Group Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 121. China National Biotec Group Main Business
Table 122. China National Biotec Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Tuberculosis Vaccines
Figure 2. Tuberculosis Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tuberculosis Vaccines Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Tuberculosis Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Tuberculosis Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Tuberculosis Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Tuberculosis Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immunotherapeutic Vaccines
Figure 12. Product Picture of Booster Vaccines
Figure 13. Product Picture of Others
Figure 14. Global Tuberculosis Vaccines Sales Market Share by Type in 2025
Figure 15. Global Tuberculosis Vaccines Revenue Market Share by Type (2020-2025)
Figure 16. Tuberculosis Vaccines Consumed in Hospitals
Figure 17. Global Tuberculosis Vaccines Market: Hospitals (2020-2025) & (K Doses)
Figure 18. Tuberculosis Vaccines Consumed in Clinics
Figure 19. Global Tuberculosis Vaccines Market: Clinics (2020-2025) & (K Doses)
Figure 20. Tuberculosis Vaccines Consumed in Others
Figure 21. Global Tuberculosis Vaccines Market: Others (2020-2025) & (K Doses)
Figure 22. Global Tuberculosis Vaccines Sale Market Share by Application (2024)
Figure 23. Global Tuberculosis Vaccines Revenue Market Share by Application in 2025
Figure 24. Tuberculosis Vaccines Sales by Company in 2025 (K Doses)
Figure 25. Global Tuberculosis Vaccines Sales Market Share by Company in 2025
Figure 26. Tuberculosis Vaccines Revenue by Company in 2025 ($ millions)
Figure 27. Global Tuberculosis Vaccines Revenue Market Share by Company in 2025
Figure 28. Global Tuberculosis Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Tuberculosis Vaccines Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Tuberculosis Vaccines Sales 2020-2025 (K Doses)
Figure 31. Americas Tuberculosis Vaccines Revenue 2020-2025 ($ millions)
Figure 32. APAC Tuberculosis Vaccines Sales 2020-2025 (K Doses)
Figure 33. APAC Tuberculosis Vaccines Revenue 2020-2025 ($ millions)
Figure 34. Europe Tuberculosis Vaccines Sales 2020-2025 (K Doses)
Figure 35. Europe Tuberculosis Vaccines Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Tuberculosis Vaccines Sales 2020-2025 (K Doses)
Figure 37. Middle East & Africa Tuberculosis Vaccines Revenue 2020-2025 ($ millions)
Figure 38. Americas Tuberculosis Vaccines Sales Market Share by Country in 2025
Figure 39. Americas Tuberculosis Vaccines Revenue Market Share by Country (2020-2025)
Figure 40. Americas Tuberculosis Vaccines Sales Market Share by Type (2020-2025)
Figure 41. Americas Tuberculosis Vaccines Sales Market Share by Application (2020-2025)
Figure 42. United States Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Tuberculosis Vaccines Sales Market Share by Region in 2025
Figure 47. APAC Tuberculosis Vaccines Revenue Market Share by Region (2020-2025)
Figure 48. APAC Tuberculosis Vaccines Sales Market Share by Type (2020-2025)
Figure 49. APAC Tuberculosis Vaccines Sales Market Share by Application (2020-2025)
Figure 50. China Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. India Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Tuberculosis Vaccines Sales Market Share by Country in 2025
Figure 58. Europe Tuberculosis Vaccines Revenue Market Share by Country (2020-2025)
Figure 59. Europe Tuberculosis Vaccines Sales Market Share by Type (2020-2025)
Figure 60. Europe Tuberculosis Vaccines Sales Market Share by Application (2020-2025)
Figure 61. Germany Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. France Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Application (2020-2025)
Figure 69. Egypt Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Tuberculosis Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Tuberculosis Vaccines in 2025
Figure 75. Manufacturing Process Analysis of Tuberculosis Vaccines
Figure 76. Industry Chain Structure of Tuberculosis Vaccines
Figure 77. Channels of Distribution
Figure 78. Global Tuberculosis Vaccines Sales Market Forecast by Region (2026-2031)
Figure 79. Global Tuberculosis Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Tuberculosis Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Tuberculosis Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Tuberculosis Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Tuberculosis Vaccines Revenue Market Share Forecast by Application (2026-2031)